Rosalind and Morris Goodman Cancer Institute

Rosalind and Morris Goodman Cancer Institute is a world-renowned cancer research centre located at McGill University in Montreal. Originally founded as the McGill Cancer Centre in 1978 through a transformative gift from businessman and philanthropist Morris Goodman, it was renamed in 2008 to honor both him and his late wife, Rosalind Goodman. The institute is dedicated to understanding the fundamental mechanisms of cancer and translating discoveries into novel strategies for prevention, diagnosis, and therapy, operating at the intersection of basic science and clinical application.

History

The institute's origins trace back to 1978 with the establishment of the McGill Cancer Centre, one of the first such dedicated facilities in Canada. Its creation was propelled by a major philanthropic donation from Morris Goodman, a prominent Montreal businessman and philanthropist. For decades, the centre built a strong reputation in oncogene and tumor suppressor research. In 2008, following an additional historic gift from the Goodman family, it was renamed the Rosalind and Morris Goodman Cancer Institute in a ceremony attended by then-Prime Minister Stephen Harper. This renaming recognized the enduring support of Morris Goodman and memorialized the legacy of his wife, Rosalind Goodman, a noted community volunteer. The institute has since expanded significantly, moving into a state-of-the-art facility on McGill University's McTavish Street campus in 2016, which consolidated its research programs under one roof.

Research

Research at the institute is organized into multidisciplinary programs focusing on the core hallmarks of cancer. Key areas of investigation include cancer metabolism, tumor microenvironment, cancer stem cells, metastasis, and DNA repair mechanisms. Scientists employ advanced models such as genetically engineered mouse models and patient-derived xenografts to study disease progression. A major translational focus involves identifying new biomarkers for early detection and developing targeted therapies, with significant work in breast cancer, prostate cancer, leukemia, and brain tumors. The institute fosters strong collaborative links with the clinical oncology community at the McGill University Health Centre and the Jewish General Hospital, facilitating the flow of discoveries from the laboratory bench to patient bedside through early-phase clinical trials.

Facilities and resources

The institute's primary home is a modern, 80,000-square-foot research pavilion on McGill University's downtown campus, opened in 2016. This facility was designed to promote collaboration, featuring open-concept laboratory spaces, shared equipment cores, and interactive common areas. Key shared resources include advanced flow cytometry, confocal microscopy, mass spectrometry, and a biobank for annotated patient samples. The building also houses the Goodman Cancer Research Centre High Throughput Screening Facility, which supports drug discovery efforts. These centralized platforms provide researchers with access to cutting-edge technology for genomics, proteomics, and cell imaging, accelerating the pace of discovery.

Notable people

The institute has been led by distinguished scientists, including its current Director, Morag Park, a renowned researcher in breast cancer and signal transduction. Past directors include Michael Pollak, an expert in cancer metabolism and insulin-like growth factor biology. The faculty comprises numerous Canada Research Chair holders and fellows of prestigious societies like the Royal Society of Canada. Notable alumni and former trainees have assumed leadership roles at major institutions worldwide, including Harvard Medical School, the Dana-Farber Cancer Institute, and the University of Toronto. The institute's research community is further strengthened by its association with Nobel laureates and other luminaries from McGill University, such as Brenda Milner and Roderick MacKinnon.

Affiliations

The institute is an integral part of McGill University's Faculty of Medicine and Health Sciences and operates as a key pillar of the university's life sciences research strategy. It maintains formal research partnerships with major Montreal hospital networks, including the McGill University Health Centre and the Centre intégré universitaire de santé et de services sociaux du Centre-Ouest-de-l'Île-de-Montréal. It is also a member of the Institut du cancer de Montréal consortium. Nationally, it collaborates with networks like the Canadian Cancer Society and the Terry Fox Research Institute. Its international affiliations include partnerships with the Ludwig Institute for Cancer Research, Cancer Research UK, and various National Institutes of Health-funded consortia in the United States.

Category:Cancer research institutes Category:McGill University Category:Medical and health organizations based in Montreal Category:Organizations established in 1978